Lori S Burton

Title: Lori S. Burton: Innovator in Pharmaceutical Compositions

Introduction

Lori S. Burton is a prominent inventor based in Robbinsville, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that target specific receptors in the human body. With a total of 2 patents, her work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Lori's latest patents include compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody combined with an anti-PD-1 or anti-PD-L1 antibody. These pharmaceutical compositions are designed to enhance the efficacy of treatments by utilizing a buffering agent, stabilizing or bulking agent, and a surfactant. Additionally, she has developed sustained release GLP-1 receptor modulators, which consist of novel pharmaceutical compositions featuring a human glucagon-like peptide-1 (GLP-1) receptor modulator as an active ingredient in a sustained release formulation.

Career Highlights

Lori S. Burton is associated with Bristol-Myers Squibb Company, where she has been instrumental in advancing research and development in the pharmaceutical sector. Her innovative approaches have led to the creation of compositions that could significantly improve patient outcomes.

Collaborations

Throughout her career, Lori has collaborated with notable colleagues, including Feng Qian and William R. Ewing. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical innovation.

Conclusion

Lori S. Burton's contributions to pharmaceutical compositions demonstrate her commitment to advancing medical science. Her innovative patents and collaborations highlight her role as a key figure in the development of effective therapeutic solutions.